Literature DB >> 24764452

Genetic dissection of tie pathway in mouse lymphatic maturation and valve development.

Bin Shen1, Zhi Shang1, Bo Wang1, Luqing Zhang1, Fei Zhou1, Taotao Li1, Man Chu1, Haijuan Jiang1, Ying Wang1, Tong Qiao1, Jun Zhang1, Wei Sun1, Xiangqing Kong1, Yulong He2.   

Abstract

OBJECTIVE: The genetic program underlying lymphatic development is still incompletely understood. This study aims to dissect the role of receptor tyrosine kinase with immunoglobulin-like and EGF (epidermal growth factor)-like domains 1 (Tie1) and Tie2 in lymphatic formation using genetically modified mouse models. APPROACH AND
RESULTS: We generated conditional knockout mouse models targeting Tie1, Tie2, and angiopoietin-2 in this study. Tie1(ΔICD/ΔICD) mice, with its intracellular domain targeted, appeared normal at E10.5 but displayed subcutaneous edema by E13.5. Lymph sac formation occurred in Tie1(ΔICD/ΔICD) mice, but they had defects with the remodeling of primary lymphatic network to form collecting vessels and valvulogenesis. Consistently, induced deletion of Tie1-ICD postnatally using a ubiquitous Cre deleter led to abnormal lymphangiogenesis and valve formation in Tie1-ICD(iUCKO/-) mice. In comparison with the lymphatic phenotype of Tie1 mutants, we found that the diameter of lymphatic capillaries was significantly less in mice deficient of angiopoietin-2, besides the disruption of collecting lymphatic vessel formation as previously reported. There was also no lymphedema observed in Ang2(-/-) mice during embryonic development, which differs from that of Tie1(ΔICD/ΔICD) mice. We further investigated whether Tie1 exerted its function via Tie2 during lymphatic development. To our surprise, genetic deletion of Tie2 (Tie2(iUCKO/-)) in neonate mice did not affect lymphatic vessel growth and maturation.
CONCLUSIONS: In contrast to the important role of Tie2 in the regulation of blood vascular development, Tie1 is crucial in the process of lymphatic remodeling and maturation, which is independent of Tie2.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  Tie-1 receptor tyrosine kinase; Tie-2 receptor tyrosine kinase; knockout mice; lymphatic abnormality; lymphatic vessel; valve

Mesh:

Substances:

Year:  2014        PMID: 24764452     DOI: 10.1161/ATVBAHA.113.302923

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  18 in total

1.  Impaired angiopoietin/Tie2 signaling compromises Schlemm's canal integrity and induces glaucoma.

Authors:  Jaeryung Kim; Dae-Young Park; Hosung Bae; Do Young Park; Dongkyu Kim; Choong-Kun Lee; Sukhyun Song; Tae-Young Chung; Dong Hui Lim; Yoshiaki Kubota; Young-Kwon Hong; Yulong He; Hellmut G Augustin; Guillermo Oliver; Gou Young Koh
Journal:  J Clin Invest       Date:  2017-09-18       Impact factor: 14.808

Review 2.  Intestinal lymphatic vasculature: structure, mechanisms and functions.

Authors:  Jeremiah Bernier-Latmani; Tatiana V Petrova
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-06-28       Impact factor: 46.802

Review 3.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

Review 4.  Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases.

Authors:  Mei-Kuang Chen; Mien-Chie Hung
Journal:  FEBS J       Date:  2015-07-04       Impact factor: 5.542

5.  Tie1 is required for lymphatic valve and collecting vessel development.

Authors:  Xianghu Qu; Bin Zhou; H Scott Baldwin
Journal:  Dev Biol       Date:  2015-01-07       Impact factor: 3.582

6.  GATA2 is required for lymphatic vessel valve development and maintenance.

Authors:  Jan Kazenwadel; Kelly L Betterman; Chan-Eng Chong; Philippa H Stokes; Young K Lee; Genevieve A Secker; Yan Agalarov; Cansaran Saygili Demir; David M Lawrence; Drew L Sutton; Sebastien P Tabruyn; Naoyuki Miura; Marjo Salminen; Tatiana V Petrova; Jacqueline M Matthews; Christopher N Hahn; Hamish S Scott; Natasha L Harvey
Journal:  J Clin Invest       Date:  2015-07-27       Impact factor: 14.808

Review 7.  Primary and secondary lymphatic valve development: molecular, functional and mechanical insights.

Authors:  Eleni Bazigou; John T Wilson; James E Moore
Journal:  Microvasc Res       Date:  2014-07-30       Impact factor: 3.514

8.  Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction.

Authors:  Seung-Jun Lee; Choong-Kun Lee; Seok Kang; Intae Park; Yoo Hyung Kim; Seo Ki Kim; Seon Pyo Hong; Hosung Bae; Yulong He; Yoshiaki Kubota; Gou Young Koh
Journal:  J Clin Invest       Date:  2018-10-08       Impact factor: 14.808

9.  Tie1 controls angiopoietin function in vascular remodeling and inflammation.

Authors:  Emilia A Korhonen; Anita Lampinen; Hemant Giri; Andrey Anisimov; Minah Kim; Breanna Allen; Shentong Fang; Gabriela D'Amico; Tuomas J Sipilä; Marja Lohela; Tomas Strandin; Antti Vaheri; Seppo Ylä-Herttuala; Gou Young Koh; Donald M McDonald; Kari Alitalo; Pipsa Saharinen
Journal:  J Clin Invest       Date:  2016-08-22       Impact factor: 14.808

Review 10.  Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems.

Authors:  Lauri Eklund; Jaakko Kangas; Pipsa Saharinen
Journal:  Clin Sci (Lond)       Date:  2017-01-01       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.